Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 088935
Company: ABRAXIS PHARM
Company: ABRAXIS PHARM
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
METHOTREXATE SODIUM | METHOTREXATE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE;INJECTION | Discontinued | None | No | No |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
08/27/1987 | SUPPL-1 | Manufacturing (CMC) |
Label is not available on this site. |